Clinical Trial Update: Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating autologous adipose-derived mesenchymal stem cells for treatment of scars and Cutis Laxa; completed phase 1/2 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cicatrix
• Cutis Laxa
• Keloid
• Scar
• Skin Disorders

Drugs mentioned

• Autologous adipose-derived mesenchymal stem cells (adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Skin, Scar | Phase 1, Phase 2 | Status: COMPLETED